what are the side effects of taking a glp 1 GLP-1 Effects: When to Call Doctor GLP-1 and Shortness of Breath:

Psychiatric Clinics of North America

Research into GLP-1 therapy shows sustained weight loss of 1522% over 68 weeks in clinical trials, with improvements in cardiovascular risk markers and metabolic syndrome features

Most patients tolerate treatment very well

mTOR is a key modulator of ageing and age-related disease

Compared with other CVOTs involving GLP-1RA, participants in the AMPLITUDE-O trial had the longest duration of diabetes (15 years), lowest mean eGFR (72 ml/min/1.73 m 2 ) with a higher percentage (32%) of people with renal disease (eGFR 2560 mL/min), highest glycosilated hemoglobin (8.9%), and highest percentage of insulin use (62%) or sodiumglucose transporter-2 inhibitors (SGLT-2i) (15%) at baseline, thus identifying a more fragile population